Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Swiss National Bank

Swiss National Bank trimmed its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 1.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 222,100 shares of the biotechnology company's stock after selling 3,700 shares during the period. Swiss National Bank owned about 0.30% of Axon Enterprise worth $57,375,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the stock. Ashburton Jersey Ltd grew its holdings in shares of Axon Enterprise by 6.9% during the fourth quarter. Ashburton Jersey Ltd now owns 15,307 shares of the biotechnology company's stock worth $3,954,000 after purchasing an additional 988 shares during the last quarter. Trinity Financial Advisors LLC bought a new position in shares of Axon Enterprise during the fourth quarter worth about $204,000. Triumph Capital Management bought a new position in Axon Enterprise in the fourth quarter valued at approximately $253,000. Brighton Jones LLC bought a new position in Axon Enterprise in the fourth quarter valued at approximately $203,000. Finally, Russell Investments Group Ltd. grew its stake in Axon Enterprise by 73.1% in the fourth quarter. Russell Investments Group Ltd. now owns 52,541 shares of the biotechnology company's stock valued at $13,575,000 after purchasing an additional 22,196 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Performance

Shares of AXON traded up $9.09 on Monday, reaching $327.64. 770,100 shares of the company's stock traded hands, compared to its average volume of 471,241. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42. The stock's 50 day simple moving average is $308.83 and its two-hundred day simple moving average is $265.60. Axon Enterprise, Inc. has a 52-week low of $175.37 and a 52-week high of $329.87. The stock has a market cap of $24.72 billion, a PE ratio of 138.50 and a beta of 0.91.


Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The business had revenue of $432.14 million during the quarter, compared to the consensus estimate of $418.97 million. On average, analysts forecast that Axon Enterprise, Inc. will post 2.44 earnings per share for the current fiscal year.

Analyst Ratings Changes

AXON has been the subject of several research analyst reports. TheStreet downgraded Axon Enterprise from a "b" rating to a "c+" rating in a research note on Tuesday, February 27th. Needham & Company LLC reaffirmed a "buy" rating and issued a $400.00 price objective on shares of Axon Enterprise in a report on Wednesday, April 24th. Robert W. Baird lifted their price target on Axon Enterprise from $260.00 to $300.00 and gave the company an "outperform" rating in a research note on Thursday, February 22nd. Barclays lifted their price target on Axon Enterprise from $296.00 to $308.00 and gave the company an "overweight" rating in a research note on Thursday, February 29th. Finally, StockNews.com lowered Axon Enterprise from a "buy" rating to a "hold" rating in a research note on Thursday, March 14th. Two equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company's stock. Based on data from MarketBeat, Axon Enterprise currently has a consensus rating of "Moderate Buy" and a consensus target price of $323.09.

Read Our Latest Report on AXON

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Recommended Stories

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Should you invest $1,000 in Axon Enterprise right now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Featured Articles and Offers

Search Headlines: